European Journal of Preventive Cardiology·26 SepAlcohol use disorder and cardiovascular risk in type 2 diabetes: beyond alcohol consumptionCohort study of 364,950 peopleAlcohol use disorderPaper
ADA Scientific Sessions 2026 Abstract·5 JunMetabolic, Hepatic, Renal, and Hemodynamic Effects of DA-2811 vs. Forxiga in Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority StudyTrial in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunEfficacy and Safety of Anagliptin Added to Metformin and Empagliflozin 25 mg in Patients with Type 2 Diabetes: A 24-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with 28-Week Open-Label ExtensionTrial in peopleInterventionsPaper